NCT05940844 Study of OB-002 in Patients With Refractory Metastatic Cancer Status WITHDRAWN Phase PHASE1
NCT05919212 Trastuzumab Deruxtecan (T-DXd): Tailoring Treatment and Companion Diagnostics (CDx) by Liquid Biopsy Status RECRUITING Phase NA
NCT05907681 Prospective Observational Study on Outcome of High-precision Hypo-fractionated Radiotherapy in Metastatic Breast Cancer (PRECISE-M) Status RECRUITING Phase N/A
NCT05894239 A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer Status RECRUITING Phase PHASE3
NCT05892068 A Study of Tucatinib Given Before Surgery to People With HER2+ Cancers That Have Spread to the Brain Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05865990 HER3-DXd in Breast Cancer and NSCLC Brain Metastases and Solid Tumor Leptomeningeal Disease Status COMPLETED Phase PHASE2
NCT05846789 SOC Chemotherapy +/- Tocilizumab for Triple Negative and ER-low Breast Cancers Status RECRUITING Phase PHASE2
NCT05833919 Second Line ERIbulin Followed by CApecitabine or the Reverse Sequence in HER2-negative Metastatic Breast Cancer Patients Status UNKNOWN Phase PHASE2
NCT05826964 Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05816655 Comparison of Clinical Efficacy Between Letrozole + Ribociclib and Fulvestrant + Letrozole + Ribociclib in Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer Status RECRUITING Phase PHASE2
NCT05810870 PIK3CA/PTEN-altered Advanced Breast Cancer Treated With MEN1611 Monotherapy or in Combination With Eribulin Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05804578 Using a Blood Test to Monitor Metastatic Breast Cancer Treatment Status RECRUITING Phase N/A
NCT05769010 Study of SHR-A1811 in HER2-expression Advanced Breast Cancer With Brain Metastases Status RECRUITING Phase PHASE2
NCT05765357 Clinical Study to Compare the Pharmacokinetics and Safety of Trastuzumab for Injection With Herceptin® in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT05760183 Discovering Factors in Metastatic Breast Cancer Patients' Clinical Trial Experiences Status NOT_YET_RECRUITING Phase N/A